These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 29115404)
1. Downregulation of mitochondrial UQCRB inhibits cancer stem cell-like properties in glioblastoma. Jung N; Kwon HJ; Jung HJ Int J Oncol; 2018 Jan; 52(1):241-251. PubMed ID: 29115404 [TBL] [Abstract][Full Text] [Related]
2. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca Shin HJ; Lee S; Jung HJ J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339 [TBL] [Abstract][Full Text] [Related]
3. Apigenin Inhibits Cancer Stem Cell-Like Phenotypes in Human Glioblastoma Cells via Suppression of c-Met Signaling. Kim B; Jung N; Lee S; Sohng JK; Jung HJ Phytother Res; 2016 Nov; 30(11):1833-1840. PubMed ID: 27468969 [TBL] [Abstract][Full Text] [Related]
4. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038 [TBL] [Abstract][Full Text] [Related]
5. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem Cells by Blocking the STAT3 Signaling Pathway. Yuk N; Jung HJ Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474197 [TBL] [Abstract][Full Text] [Related]
7. The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells. Lee S; Kwon MC; Jang JP; Sohng JK; Jung HJ Int J Oncol; 2017 Aug; 51(2):414-424. PubMed ID: 28656196 [TBL] [Abstract][Full Text] [Related]
8. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
9. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931 [TBL] [Abstract][Full Text] [Related]
10. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction. Guo H; Liu C; Yang L; Dong L; Wang L; Wang Q; Li H; Zhang J; Lin P; Wang X Mol Carcinog; 2016 Jan; 55(1):77-89. PubMed ID: 25557841 [TBL] [Abstract][Full Text] [Related]
11. Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock. Dong Z; Zhang G; Qu M; Gimple RC; Wu Q; Qiu Z; Prager BC; Wang X; Kim LJY; Morton AR; Dixit D; Zhou W; Huang H; Li B; Zhu Z; Bao S; Mack SC; Chavez L; Kay SA; Rich JN Cancer Discov; 2019 Nov; 9(11):1556-1573. PubMed ID: 31455674 [TBL] [Abstract][Full Text] [Related]
12. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells. Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells. Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C Stem Cell Res; 2013 Jul; 11(1):601-10. PubMed ID: 23651583 [TBL] [Abstract][Full Text] [Related]
15. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway. Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966 [TBL] [Abstract][Full Text] [Related]
16. ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells. Chen X; Chen L; Zhang R; Yi Y; Ma Y; Yan K; Jiang X; Wang X Neurosci Lett; 2013 Mar; 537():44-9. PubMed ID: 23356982 [TBL] [Abstract][Full Text] [Related]
17. Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like Properties. Im CN; Yun HH; Lee JH Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241425 [TBL] [Abstract][Full Text] [Related]
18. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism. Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852 [TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells. Li GH; Wei H; Lv SQ; Ji H; Wang DL Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]